Bellicum Pharmaceuticals, Inc(NASDAQ:BLCM) 
Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX...
Website: http://www.bellicum.com
Founded: 2004
Full Time Employees: 107
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-09-05
P
O 0.34
H 0.34
L 0.32
C 0.32
V 657
10EMA 0.32
20EMA 0.32
60EMA 0.32
120EMA 0.32
250EMA 0.32